Inactive Instrument

Coloplast Stock CINNOBER BOAT

Equities

0QBO

DK0060448595

Medical Equipment, Supplies & Distribution

Real-time Estimate Cboe Europe 07:59:42 2024-07-16 EDT 5-day change 1st Jan Change
852.9 DKK 0.00% Intraday chart for Coloplast 0.00% 0.00%

Financials

Sales 2024 * 27.02B 3.95B 5.4B Sales 2025 * 29.35B 4.29B 5.86B Capitalization 195B 28.53B 39.01B
Net income 2024 * 5.23B 764M 1.04B Net income 2025 * 6.11B 893M 1.22B EV / Sales 2024 * 7.95 x
Net Debt 2024 * 19.51B 2.85B 3.9B Net Debt 2025 * 18.07B 2.64B 3.61B EV / Sales 2025 * 7.27 x
P/E ratio 2024 *
37.4 x
P/E ratio 2025 *
32 x
Employees -
Yield 2024 *
2.33%
Yield 2025 *
2.53%
Free-Float 58.53%
More Fundamentals * Assessed data
Dynamic Chart
Managers TitleAgeSince
Chief Executive Officer 54 07-12-31
Director of Finance/CFO 52 05-12-31
Chairman 65 87-12-31
Members of the board TitleAgeSince
Director/Board Member 76 68-09-30
Director/Board Member 60 17-11-30
Chairman 65 87-12-31
More insiders
Coloplast A/S specializes in the design, manufacturing, and marketing of disposable medical products. Net sales break down by family of products as follows: - hygiene products (43.4%): urine bags, plugs, urinary testing systems and sets, etc.; - ostomy care products (36.8%): bags and equipment used following intestinal operations; - wound care and skincare products (11.9%): wound dressings, bandages, creams and gels; - voice and respiratory care products (7.9%): voice prostheses for speaking, adhesives, laryngectomy cannulas for breathing, hands-free speaking devices, etc. Net sales are distributed geographically as follows: Denmark (1.4%), the United States (21%), the United Kingdom (14%), France (10.8%) and other (52.8%).
Calendar
More about the company